Dr. Jiaying Tan, Ph.D.

Dr. Jiaying Tan

Head of Strategy & Partnership in Greater China / Snr. Scientific Editor
Cell Press / Cell
BioGRAPHY

Dr. Jiaying Tan is the Head of Strategy and Partnership in Greater China at Cell Press, and a Senior Scientific Editor at Cell. She earned her PhD in Molecular and Cellular Pathology in the University of Michigan-Ann Arbor in 2012, before moving to the Novartis Institutes for BioMedical Research in Shanghai to conduct postdoctoral research in cancer biology. She joined the Cell editorial team in 2013. During the past few years, she has also served as a consulting editor at Cell Reports, the acting Editor-in-Chief of The Lancet Haematology from July 2018 to January 2019, and the co-acting Editor-in-Chief of Cancer Cell from October 2019 to February 2020.

Speaker's Schedule

Dec 21, 2022
12:30 - 13:45
Meeting the Editor | Live from Hangzhou site
Publishing at Cell
Cell publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. The basic criterion for considering papers is whether the results provide significant conceptual advances into, or raise provocative questions and hypotheses regarding, an interesting and important biological question. In addition to primary research articles in four formats, Cell features review and opinion articles on recent research advances and issues of interest to its broad readership in the leading edge section.
Hosted by Dr. Hongtao Yu, Dean, School of Life Sciences, Westlake University.
VIEW HANGZHOU PROGRAM